Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/142542
Registo completo
Campo DCValorIdioma
dc.creatorOliveira, MC
dc.creatorCaires, HR
dc.creatorOliveira, MJ
dc.creatorFraga, A
dc.creatorVasconcelos, MH
dc.creatorRibeiro, R
dc.date.accessioned2022-08-01T11:22:48Z-
dc.date.available2022-08-01T11:22:48Z-
dc.date.issued2020
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/10216/142542-
dc.description.abstractExtracellular vesicles (EVs) are small membrane vesicles released by all cells and involved in intercellular communication. Importantly, EVs cargo includes nucleic acids, lipids, and proteins constantly transferred between different cell types, contributing to autocrine and paracrine signaling. In recent years, they have been shown to play vital roles, not only in normal biological functions, but also in pathological conditions, such as cancer. In the multistep process of cancer progression, EVs act at different levels, from stimulation of neoplastic transformation, proliferation, promotion of angiogenesis, migration, invasion, and formation of metastatic niches in distant organs, to immune escape and therapy resistance. Moreover, as products of their parental cells, reflecting their genetic signatures and phenotypes, EVs hold great promise as diagnostic and prognostic biomarkers. Importantly, their potential to overcome the current limitations or the present diagnostic procedures has created interest in bladder cancer (BCa). Indeed, cystoscopy is an invasive and costly technique, whereas cytology has poor sensitivity for early staged and low-grade disease. Several urine-based biomarkers for BCa were found to overcome these limitations. Here, we review their potential advantages and downfalls. In addition, recent literature on the potential of EVs to improve BCa management was reviewed and discussed.
dc.description.sponsorshipThe work of our laboratory is funded by FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT - Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Ensino Superior in the framework of the project "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274). The authors acknowledge Christophe de Sousa for figure sketching.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofCancers, vol.12(6):1400
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleUrinary biomarkers in bladder cancer: Where do we stand and potential role of extracellular vesicles
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/cancers12061400
dc.relation.publisherversionhttps://www.mdpi.com/2072-6694/12/6/1400
Aparece nas coleções:ICBAS - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.3390-cancers12061400.pdf1.58 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons